Intractable Pain

18 registered clinical trials studyying Intractable Pain — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain NCT02522611	National Institute of Neurological Disorders and Stroke (NINDS)	Phase 1 / Phase 2
Not Yet Recruiting	Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stim NCT07507422	Medtronic	—
Not Yet Recruiting	MRI Evaluation of Spinal Cord Edema After CT-Guided Percutaneous Cordotomy in Cancer Pain Patients NCT07400055	Mersin University	—
Recruiting	Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control NCT07190807	Boston Scientific Corporation	N/A
Completed	Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial NCT04909593	Boston Scientific Corporation	N/A
Withdrawn	Transitioning to a Valve -Gated Intrathecal Drug Delivery System (IDDS) NCT03876158	Rush University Medical Center	Phase 4
Terminated	Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products NCT03886753	Children's Hospital of Philadelphia	—
Completed	Multi-center Prospective Study Determining the Sustainability of Pain Relief and Psychosocial and Functional R NCT03082261	Abbott Medical Devices	N/A
Terminated	Ketamine and Refractory Painful Care in a Palliative Unit NCT02587130	Lille Catholic University	Phase 4
Completed	Prometra Post-Approval Study NCT01854229	Flowonix Medical	N/A
Completed	NP2 Enkephalin For Treatment of Intractable Cancer Pain NCT01291901	Diamyd Inc	Phase 2
Unknown	Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cance NCT00996983	National Cancer Institute, Naples	Phase 2
Recruiting	Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer NCT00804154	National Institute of Dental and Craniofacial Research (NIDCR)	Phase 1
Completed	Intrathecal Morphine Administration Using Implantable Pump With Continuous or Programmable Flow NCT01567345	Institut Cancerologie de l'Ouest	N/A
Completed	Prometra's Utilization in Mitigating Pain (PUMP) NCT00817596	Flowonix Medical	N/A
Completed	Behavioral Treatments for Chronic Pain NCT00371865	US Department of Veterans Affairs	N/A
Terminated	Efficacy of the Spinal Cord Stimulation System as Salvage Therapy NCT00387244	Boston Scientific Corporation	N/A
Approved For Marketing	Prometra's Utilization in Mitigating Pain II NCT00866164	Flowonix Medical	—